UDD Logo
CRIS - Current Research Information System
New user? Click here to register.Have you forgotten your password?
Communities & Collections
Research Outputs
Fundings & Projects
Researchers
Datasets
Statistics
  1. Home
  2. CRIS
  3. Publications
  4. Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study
Details

Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study

Journal
Vaccine: X
ISSN
2590-1362
Date Issued
2023
Author(s)
HORMAZABAL CASTILLO, JUAN PATRICIO  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Loreto Nuñez-Franz
RUBILAR RAMIREZ, PAOLA ANDREA  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
APABLAZA SALINAS, MAURICIO IVÁN  
Facultad de Gobierno  
VIAL COX, MARIA CECILIA  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
CORTES SALINAS, LINA JIMENA  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Macarena Said
Kathya Olivares
VIAL CLARO, PABLO AGUSTIN  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Muriel Ramírez-Santana
GONZALEZ WIEDMAIER, CLAUDIA MARTA  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Natalia González
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
AGUILERA SANHUEZA, XIMENA PAZ  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Type
Resource Types::text::journal::journal article
Scopus ID
2-s2.0-85170548846
WoS ID
WOS:001077951300001
DOI
10.1016/j.jvacx.2023.100372
URL
https://investigadores.udd.cl/handle/123456789/8404
URL Institutional Repository
https://hdl.handle.net/11447/8848
Cite this document
Hormazábal, J., Nuñez-Franz, L., Rubilar, P., Apablaza, M., Vial, C., Cortés, L. J., González, N., Vial, P., Said, M., González, C., Olivares, K., Aguilera, X., & Ramírez-Santana, M. (2023). Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study. Vaccine: X, 15, 100372. https://doi.org/10.1016/j.jvacx.2023.100372
Project(s)
Estudio de seroprevalencia seriada: seguimiento de la inmunidad a la infección por SARS-Cov-2 y monitoreo de cobertura efectiva de vacunación, en dos ciudades chilenas  
Subjects
chile

; 

covid-19

; 

immunity

; 

neutralizing antibodies

; 

territorial population

; 

vaccine effectiveness

; 

coronavac

; 

elasomeran

; 

immunoglobulin g

; 

neutralizing antibody

; 

sars-cov-2 vaccine

; 

tozinameran

; 

vaxzevria

; 

adolescent

; 

adult

; 

aged

; 

aging

; 

antibody response

; 

antibody titer

; 

article

; 

child

; 

chile

; 

comparative study

; 

controlled study

; 

coronavirus disease 2019

; 

drug efficacy

; 

drug targeting

; 

female

; 

human

; 

human cell

; 

major clinical study

; 

male

; 

sars-cov-2 omicron

; 

seroprevalence

; 

treatment refusal

; 

vaccination coverage

; 

virus immunity

; 

virus load
Logo Universidad de Desarrollo
Encuéntranos en:

Sede Santiago

Av. Plaza 680, Las Condes

Contacto|Mapa

Sede Concepción

Ainavillo 456, Concepción

Contacto|Mapa

Hosting & SupportLogo Scimago Lab

Built with DSpace-CRIS software - Extension maintained and optimized by 4science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify